Numinus Execs: No Quick Pathway for Psychedelics

Our founders Payton Nyquvest and Stacey Wallin sat down with Investing News Network to talk about how Numinus is setting the table for psychedelic therapy and what investors should expect as the industry matures. Click here to read the accompanying article.